Surgepays Inc Financials
Surgepays Inc (SURG) reported $57.0M in revenue for fiscal year 2025, down 6.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue reset has coincided with gross losses, cash consumption, and financing-dependent liquidity, revealing a deteriorating operating model.
The FY2023 earnings inflection did not persist: operating cash flow reached$10.3M alongside net income of$20.6M . By FY2025, operating cash flow was-$21.3M against a net loss of-$36.1M , indicating a reversal in operating economics rather than merely non-cash accounting noise.
Revenue fell from
FY2025's current ratio of 0.4x paired with cash of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Surgepays Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Surgepays Inc, and counted as zero in the overall score.
Not available for Surgepays Inc, and counted as zero in the overall score.
Surgepays Inc scores -23.89, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($7.1M) relative to total liabilities ($23.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Surgepays Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Surgepays Inc reported a net loss of $36.1M while operations used $21.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Surgepays Inc reported an operating loss of $34.1M against $2.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Surgepays Inc generated $57.0M in revenue in fiscal year 2025. This represents a decrease of 6.4% from the prior year.
Surgepays Inc's EBITDA was -$33.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 20.2% from the prior year.
Surgepays Inc reported -$36.1M in net income in fiscal year 2025. This represents an increase of 21.1% from the prior year.
Surgepays Inc earned -$1.80 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.7% from the prior year.
Cash & Balance Sheet
Surgepays Inc recorded an outflow of $21.3M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 2.4% from the prior year.
Surgepays Inc held $1.7M in cash against $15.2M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Surgepays Inc's gross margin was -18.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 4.9 percentage points from the prior year.
Surgepays Inc's operating margin was -59.9% in fiscal year 2025, reflecting core business profitability. This is up 11.5 percentage points from the prior year.
Surgepays Inc's net profit margin was -63.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 11.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Surgepays Inc invested $19K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.4% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
SURG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.4M | $57.0M-6.4% | $60.9M-55.6% | $137.1M+12.8% | $121.5M+138.0% | $51.1M-6.2% | $54.4M+111.3% | $25.7M+68.9% | $15.2M+13.3% | $13.5M+308.3% | $3.3M+16.4% | $2.8M+5.9% | $2.7M-11.9% | $3.0M | $1K-30.7% | $2K |
| Cost of Revenue | $77.7M | $67.6M-10.2% | $75.2M-25.9% | $101.5M-6.1% | $108.1M+140.8% | $44.9M-13.6% | $51.9M+129.6% | $22.6M+164.0% | $8.6M+5.9% | $8.1M+247.7% | $2.3M-0.2% | $2.3M+39.0% | $1.7M-18.3% | $2.1M | N/A | N/A |
| Gross Profit | -$15.3M | -$10.6M+26.1% | -$14.3M-140.2% | $35.6M+164.6% | $13.5M+118.3% | $6.2M+149.9% | $2.5M-20.9% | $3.1M-53.3% | $6.7M+24.4% | $5.4M+454.0% | $968K+93.4% | $501K-49.8% | $997K+1.5% | $982K | N/A | N/A |
| SG&A Expenses | $18.9M | $20.1M-26.9% | $27.5M+63.7% | $16.8M+30.7% | $12.8M+5.5% | $12.2M-3.6% | $12.6M+18.3% | $10.7M+32.3% | $8.1M+56.4% | $5.2M+57.6% | $3.3M+147.6% | $1.3M+36.8% | $965K+14.7% | $842K | N/A | N/A |
| Operating Income | -$37.8M | -$34.1M+21.5% | -$43.5M-330.4% | $18.9M+2876.6% | $634K+110.6% | -$6.0M+40.9% | -$10.1M-30.6% | -$7.8M-405.9% | -$1.5M-851.6% | $204K+106.6% | -$3.1M-135.2% | -$1.3M-4331.6% | $31K-77.8% | $141K | N/A | N/A |
| Interest Expense | $2.8M | $2.0M+261.6% | $554K | N/A | $400K | N/A | N/A | N/A | N/A | N/A | N/A | $15K+26.1% | $12K-32.3% | $18K | N/A | $13K |
| Income Tax | N/A | N/A | $2.9M+226.7% | -$2.3M | N/A | N/A | N/A | N/A | $82K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$40.5M | -$36.1M+21.1% | -$45.7M-321.8% | $20.6M+3128.6% | -$681K+95.0% | -$13.5M-26.2% | -$10.7M-26.9% | -$8.4M-448.1% | -$1.5M-155.7% | $2.8M+160.2% | -$4.6M-244.3% | -$1.3M-4112.4% | $33K-64.9% | $95K | N/A | N/A |
| EPS (Diluted) | — | -$1.80+24.7% | -$2.39-273.2% | $1.38+2860.0% | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SURG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.5M-64.5% | $24.0M-42.8% | $41.9M+23.3% | $34.0M+74.4% | $19.5M+166.2% | $7.3M-26.6% | $10.0M+144.5% | $4.1M+32.7% | $3.1M+30.5% | $2.4M-10.3% | $2.6M+79.5% | $1.5M+142.5% | $604K | $3K-2.3% | $3K |
| Current Assets | $7.0M-60.9% | $17.9M-46.4% | $33.4M+21.1% | $27.6M+98.4% | $13.9M+1010.5% | $1.3M-65.0% | $3.6M+16.8% | $3.1M+2.4% | $3.0M+293.9% | $759K+119.3% | $346K+6.8% | $324K-45.8% | $598K | $726+6.3% | $683 |
| Cash & Equivalents | $1.7M-85.3% | $11.8M-19.4% | $14.6M+107.8% | $7.0M+12.0% | $6.3M+832.3% | $674K+94.8% | $346K-22.2% | $445K-65.1% | $1.3M+190.1% | $439K+532.1% | $69K+83.8% | $38K-70.3% | $127K | $482+52.5% | $316 |
| Inventory | $340K-80.9% | $1.8M-80.3% | $9.0M-19.1% | $11.2M+156.6% | $4.4M+2344.8% | $178K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $4.0M+34.8% | $3.0M-68.5% | $9.5M+3.3% | $9.2M+184.0% | $3.2M+1700.5% | $180K-94.1% | $3.1M+1378.7% | $207K+3640.8% | $6K-95.6% | $126K-54.0% | $275K-2.3% | $282K-39.8% | $468K | $244-33.5% | $367 |
| Goodwill | N/A | $3.3M+98.0% | $1.7M0.0% | $1.7M+92.3% | $867K0.0% | $867K0.0% | $867K0.0% | $867K0.0% | $867K0.0% | $867K | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $23.9M+174.5% | $8.7M-35.6% | $13.5M-53.2% | $28.9M+81.1% | $15.9M-11.6% | $18.1M+22.9% | $14.7M+141.8% | $6.1M+64.4% | $3.7M-35.6% | $5.7M+77.4% | $3.2M+126.1% | $1.4M+36.7% | $1.0M | $834K+8.1% | $772K |
| Current Liabilities | $18.2M+200.2% | $6.1M-52.3% | $12.7M-45.9% | $23.5M+134.7% | $10.0M-36.2% | $15.7M+122.0% | $7.1M+47.2% | $4.8M+70.5% | $2.8M-30.8% | $4.1M+56.3% | $2.6M+308.8% | $635K+84.4% | $344K | $834K+8.1% | $772K |
| Long-Term Debt | $15.2M+278.8% | $4.0M-20.2% | $5.0M-34.2% | $7.7M | N/A | $1.1M-49.2% | $2.2M+224.3% | $680K+1203.0% | $52K-11.0% | $59K-89.5% | $556K-30.1% | $795K+13.2% | $702K | N/A | N/A |
| Total Equity | -$15.3M-200.2% | $15.3M-45.8% | $28.2M+466.0% | $5.0M+40.5% | $3.6M+133.1% | -$10.7M-128.2% | -$4.7M-136.4% | -$2.0M-222.1% | -$617K+81.7% | -$3.4M-457.1% | -$607K-1934.3% | $33K+107.5% | -$443K | -$831K-8.1% | -$769K |
| Retained Earnings | -$97.0M-59.2% | -$60.9M-301.1% | -$15.2M+57.6% | -$35.8M-1.9% | -$35.1M-62.7% | -$21.6M-98.6% | -$10.9M-348.5% | -$2.4M-292.6% | -$617K+89.8% | -$6.0M-322.2% | -$1.4M-20524.1% | -$7K | N/A | -$3.7M-1.7% | -$3.6M |
SURG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$18.9M | -$21.3M+0.1% | -$21.3M-307.2% | $10.3M+1196.8% | $793K+105.2% | -$15.3M-253.4% | -$4.3M+33.8% | -$6.5M-543.3% | -$1.0M-545.8% | $228K+135.5% | -$642K-185.9% | -$225K-364.6% | $85K+155.4% | $33K | N/A | N/A |
| Capital Expenditures | N/A | $19K-96.4% | $518K | N/A | $11K-77.8% | $51K+678.3% | $7K-97.1% | $228K-31.4% | $332K+125.7% | $147K+4800.0% | $3K-69.2% | $10K | N/A | $1K | N/A | N/A |
| Free Cash Flow | N/A | -$21.3M+2.4% | -$21.8M | N/A | $782K+105.1% | -$15.3M-254.0% | -$4.3M+35.9% | -$6.8M-401.8% | -$1.3M-1767.6% | $81K+112.5% | -$645K-175.3% | -$234K | N/A | $32K | N/A | N/A |
| Investing Cash Flow | N/A | -$19K+99.4% | -$3.0M-968.1% | -$281K+81.2% | -$1.5M-297.8% | -$377K-4609.5% | $8K+125.9% | -$32K+88.4% | -$278K-89.1% | -$147K+70.8% | -$503K-2844.0% | $18K | N/A | -$1K | $0 | N/A |
| Financing Cash Flow | $15.9M | $10.5M-53.1% | $22.5M+1029.2% | -$2.4M-266.0% | $1.5M-93.1% | $21.3M+357.9% | $4.6M-28.2% | $6.5M+1293.4% | $464K-23.6% | $607K-46.7% | $1.1M+378.9% | $238K+230.1% | -$183K-1802.9% | $11K | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | $500K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
SURG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY13 | FY12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -18.6%+4.9pp | -23.5%-49.5pp | 26.0%+14.9pp | 11.1%-1.0pp | 12.1%+7.5pp | 4.5%-7.6pp | 12.1%-31.7pp | 43.8%+3.9pp | 39.9%+10.5pp | 29.4%+11.7pp | 17.7%-19.6pp | 37.3%+4.9pp | 32.4% | N/A | N/A |
| Operating Margin | -59.9%+11.5pp | -71.4%-85.1pp | 13.8%+13.2pp | 0.5%+12.3pp | -11.7%+6.9pp | -18.6%+11.5pp | -30.2%-20.1pp | -10.1%-11.6pp | 1.5%+95.8pp | -94.2%-47.6pp | -46.6%-47.8pp | 1.2%-3.5pp | 4.6% | N/A | N/A |
| Net Margin | -63.3%+11.8pp | -75.1%-90.1pp | 15.0%+15.6pp | -0.6%+25.9pp | -26.5%-6.8pp | -19.7%+13.1pp | -32.8%-22.7pp | -10.1%-30.7pp | 20.6% | -139.5% | -47.2%-48.4pp | 1.3%-1.9pp | 3.1% | N/A | N/A |
| Return on Equity | N/A | -298.6%-371.6pp | 73.0%+86.6pp | -13.6%+367.4pp | -381.0% | N/A | N/A | N/A | N/A | N/A | N/A | 100.7% | N/A | N/A | N/A |
| Return on Assets | -423.6%-232.8pp | -190.7%-239.9pp | 49.2%+51.2pp | -2.0%+67.4pp | -69.4%+77.0pp | -146.4%-61.8pp | -84.6%-46.9pp | -37.7%-127.7pp | 90.0%+285.1pp | -195.2%-144.3pp | -50.9%-53.1pp | 2.3%-13.4pp | 15.7% | N/A | N/A |
| Current Ratio | 0.38-2.6x | 2.95+0.3x | 2.63+1.5x | 1.17-0.2x | 1.39+1.3x | 0.08-0.4x | 0.51-0.1x | 0.64-0.4x | 1.06+0.9x | 0.19+0.1x | 0.13-0.4x | 0.51-1.2x | 1.74 | 0.000.0x | 0.00 |
| Debt-to-Equity | N/A | 0.26+0.1x | 0.18-1.4x | 1.54-3.0x | 4.49 | N/A | N/A | N/A | N/A | N/A | N/A | 24.03 | N/A | N/A | N/A |
| FCF Margin | -37.4%-1.6pp | -35.9% | N/A | 0.6%+30.7pp | -30.0%-22.1pp | -8.0%+18.3pp | -26.3%-17.4pp | -8.8%-9.4pp | 0.6%+20.2pp | -19.6%-11.3pp | -8.3% | N/A | 1.1% | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: Shareholder equity is negative (-$15.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.38), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Surgepays Inc Ranks
Frequently Asked Questions
What is Surgepays Inc's annual revenue?
Surgepays Inc (SURG) reported $57.0M in total revenue for fiscal year 2025. This represents a -6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Surgepays Inc's revenue growing?
Surgepays Inc (SURG) revenue declined by 6.4% year-over-year, from $60.9M to $57.0M in fiscal year 2025.
Is Surgepays Inc profitable?
No, Surgepays Inc (SURG) reported a net income of -$36.1M in fiscal year 2025, with a net profit margin of -63.3%.
What is Surgepays Inc's EBITDA?
Surgepays Inc (SURG) had EBITDA of -$33.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Surgepays Inc have?
As of fiscal year 2025, Surgepays Inc (SURG) had $1.7M in cash and equivalents against $15.2M in long-term debt.
What is Surgepays Inc's gross margin?
Surgepays Inc (SURG) had a gross margin of -18.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Surgepays Inc's operating margin?
Surgepays Inc (SURG) had an operating margin of -59.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Surgepays Inc's net profit margin?
Surgepays Inc (SURG) had a net profit margin of -63.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Surgepays Inc's free cash flow?
Surgepays Inc (SURG) recorded an outflow of $21.3M in free cash flow during fiscal year 2025. This represents a 2.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Surgepays Inc's operating cash flow?
Surgepays Inc (SURG) recorded an outflow of $21.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Surgepays Inc's total assets?
Surgepays Inc (SURG) had $8.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Surgepays Inc's capital expenditures?
Surgepays Inc (SURG) invested $19K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Surgepays Inc's current ratio?
Surgepays Inc (SURG) had a current ratio of 0.38 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Surgepays Inc's return on assets (ROA)?
Surgepays Inc (SURG) had a return on assets of -423.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Surgepays Inc's cash runway?
Based on fiscal year 2025 data, Surgepays Inc (SURG) had $1.7M in cash against an annual operating cash burn of $21.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Surgepays Inc's debt-to-equity ratio negative or not reported?
Surgepays Inc (SURG) has negative shareholder equity of -$15.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Surgepays Inc's Altman Z-Score?
Surgepays Inc (SURG) has an Altman Z-Score of -23.89, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Surgepays Inc's Piotroski F-Score?
Surgepays Inc (SURG) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Surgepays Inc's earnings high quality?
Surgepays Inc (SURG) reported a net loss of $36.1M while operations used $21.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Surgepays Inc cover its interest payments?
Surgepays Inc (SURG) reported an operating loss of $34.1M against $2.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Surgepays Inc?
Surgepays Inc (SURG) scores 11 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.